implantable cardioverter defibrillator, electromagnetic interference, oversensing Introduction Implantable cardioverter defibrillators (ICDs) reduce mortality in patients with malignant ventricular arrhythmias.
Introduction
Implantable cardioverter defibrillators (ICDs) reduce mortality in patients with malignant ventricular arrhythmias. 1−5 However, ICDs can have a negative impact on quality of life measures. 6 One of the most important factors influencing the quality of life after a medical intervention is the ability to return to work. 7 Patients with ICDs are often advised to quit industrial jobs because of concerns that strong electromagnetic fields operating in the industrial environment might interfere with the device's normal function.
Electromagnetic interference (EMI) can alter ICD's function in several ways: (1) Electrical signals within the frequency range of the ICD's sensing circuitry can induce false detection of arrhythmias and result in inappropriate therapy. 8, 9 (2) Sensed external electromagnetic noise may prevent detection of actual ventricular arrhythmias, preventing the delivery of lifesaving therapy. 10 (3) EMI can cause the defibrillator to revert to a "protection mode" changing its programmed parameters to the default values.
10 (4) A strong magnetic field can close the reed switch of the device, causing it to be inhibited. 11 The purpose of our investigation was to devise a simple, low risk screening protocol that will help ICD patients, physicians, and employers assess the risks of EMI in the industrial workplace.
Methods

Patients and Devices
The study group was comprised of 18 patients with ICDs (3 women) with a mean age of 51.4 ± 14.7 (range: 23-77) years. All patients received an ICD because of documented sustained ventricular arrhythmias, and none had a pacing indication. Nine different models of ICD's were implanted (Table I ). All ICDs were manufactured by Guidant/CPI (St. Paul, MN, USA). The devices used can be programmed to emit an audible tone for each sensed QRS and a special tone if EMI is sensed. This feature enables continuous monitoring of the device's sensing during daily activities GUREVITZ, ET AL. without the need to apply a magnet or suspend therapy. Fourteen patients had pectoral implants. All but one used a nonthoracotomy Endotak lead system (Guidant/CPI).
Testing Procedure
The study involved three stages:
Stage 1: At baseline all devices were interrogated. The magnet response was tested and the markers, magnet, and QRS beeper were enabled. One to one sensing correlating QRS detection and the beep tones were verified. Detection duration was extended to 15 seconds for each therapy zone while the ICD remained fully active. We did not feel that it was safe to inactivate ICD therapy without an external defibrillator immediately available, and thus chose to extend the arrhythmia detection duration for each therapy zone. Stage 2: Each patient was asked to walk through their workplace and operate each item of equipment as they would during their usual activities. The device's QRS beeper was monitored with a stethoscope by a clinical engineer or nurse specially trained to work with ICDs. Each item was recorded as well as the approximate distance to the patient and the effects on the device's sensing. The engineer or nurse was instructed to apply a magnet and remove the patient from a source should oversensing occur. Stage 3: At the conclusion of testing, all programmed parameters were returned to their initial values. The devices were interrogated and final parameters were compared with the initial values.
Follow-Up
Seventeen patients were contacted by phone 46 ± 6 months after initial testing. One patient was lost to follow-up. Patients were asked to give details regarding current employment status, reasons for retirement, and history of ICD shocks and syncopal spells during work. If a patient reported being shocked or experiencing syncope during work, the relevant pacemaker clinic was contacted and data regarding the event obtained.
Results
Testing Results
Between October 1995 and February 1998, 18 patients with ICDs requested testing in order to resume 11 different job positions at 13 different industrial facilities (Table II) . In these patients, 184 contacts with 114 different types of equipment were recorded, including 31 with arc welding machines. The distance measured between the patient and the equipment ranged from zero (touching in 5 patients) to 360 inches, with a mean of 24.8 ± 54.8 inches. In only one instance was interference recorded when a worker in a steel facility was responsible for attaching a huge electromagnet to a crane. In this patient ICD therapy was temporarily inhibited while within 6 feet of the electromagnet. He was advised to change jobs. There were no other cases of oversensing in the other 183 contacts that were monitored. Similarly, we did not observe any changes in the devices' programmed parameters after any of these encounters.
Follow-Up
Follow-up data were obtained for 17 (94%) patients 46.0 ± 9.0 (range 32-60) months after testing (Table III) . One patient was lost to followup. At the time of follow-up, 7 (41%) patients were still working in the same position they held at the time of testing. Seven patients had retired 15.9 ± 10.0 months after testing. Reasons for retirement included: congestive heart failure in two patients, age, inner ear disease, cerebrovascular event, asthma, and childbearing in one patient each. Three patients changed to a nonindustrial job 5, 23, and 25 months after testing. Two of them said that they preferred to avoid the industrial workplace because they were concerned about potential interactions with their devices. None of them reported being shocked or experienced loss of consciousness while at work. During the follow-up period, only one patient reported having an ICD discharge while at work. Data obtained from his pacemaker clinic revealed no shock episodes according to the device's interrogation, and reproduction of the same "shock" sensation occurred by bending the head. The symptoms were attributed to vertebral discopathy. This patient continued to work as a welder at the time of follow-up 37 months after the reported "event." No patient reported syncope during work.
Discussion Electromagnetic Interference in the Workplace
Interference of environmental electromagnetic fields with the function of cardiac pacemakers is well reported. 12 Since ICDs became widely used in the mid 1980s, several case reports have described either the inappropriate delivery of shocks 8, 9 or the inactivation of devices by EMI.
11
So far only few studies systematically addressed the effects of EMI in the workplace on patients with implanted devices. Marco et al. 13 investigated 12 pacemaker patients in the industrial environment. They found that arc welding machines delivering up to 225 A did not adversely interfere with pacemaker function. However, a submerged arc welder using up to 1,000 A inhibited his pacemaker when the pacemaker was within 15 centimeters of the welding site. In a recent study, Fetter et al. 14 interrogated ICDs of 11 patients immediately after they had operated different arc welding machines or were working near high power motors. In none of their cases did oversensing occur. Our findings are in agreement with these data. During routine work in industrial facilities, we were able to record oversensing by an ICD in only one of 184 encounters (0.5%). We did not detect any reprogramming or reed switch closure. Differing from previous studies, we provide long-term follow-up. Our follow-up results help support the findings of initial testing and provide evidence for the reliability of our testing protocol. All but one patient were allowed to return to their previous work after testing. None of them had ICD discharges or syncope during work, and 46 months after testing, 41% of them still work in the industrial setting.
Factors Influencing Interference
The main factors determining whether an electromagnetic source will interfere with an ICD's functions are the frequency of the emitted electrical signals, the magnitude of the magnetic field, and the spatial orientation and proximity of the source to the device. Because one of our goals was to devise a simple and practical way of screening, we did not measure the electromagnetic fields operating in our patients' workplaces. However, Fetter et al.
14 recorded the power rating of electrical equipment very similar to that used by our patients. According to their report, AC arc welders use from 2 to 375 A while DC arc welding machines use up to 900 A. The magnetic flux density they measured at the surface of cables or motors ranged between 40 and 2,530 G and decreased to 0.5 to1.2 G at a distance of 1 to 2 feet from the surface. The minimal magnet field that is required to cause reed switch closure (i.e, inactivation) of an ICD is 10 G. No oversensing occurred when ICD patients were instructed to keep a minimal distance of 1 foot from the equipment they were using.
14 In contrast, we did not instruct our patients about the distance they should keep from their equipment, but instead recorded the actual distance they kept during usual daily tasks. With an average distance of 24.8 ± 54.8 inches (ranging 0-360 inches) no oversensing was recorded during 183 of 184 contacts monitored. ICD therapy was temporarily suspended at a distance of up to 6 feet from a very powerful electromagnet in one patient.
Study Limitations
One limitation of our study is that devices from only one manufacturer (CPI/Guidant) were assessed. It is possible that other ICDs and lead systems might respond differently. Also, electromagnetic fields in a specific workplace may change over time because of wear and tear or the replacement of machines. A change in the patient's distance from a machine or mode of operation can also influence the probability of EMI. Thus, alterations in the workplace may warrant a new testing procedure.
Conclusions
Our findings suggest that patients who receive an ICD, typically can resume work in industrial facilities after appropriate individual testing is performed. In the event that the patient experiences lightheadedness or a shock, they must be removed immediately from the source and seek medical evaluation. Any change made in the equipment operated by the patient or in their ICD warrants retesting for possible interactions.
